MELD 3.0 adequately predicts mortality and renal replacement therapy requirements in patients with alcohol-associated hepatitis
Titel:
MELD 3.0 adequately predicts mortality and renal replacement therapy requirements in patients with alcohol-associated hepatitis
Auteur:
Díaz, Luis Antonio Fuentes-López, Eduardo Ayares, Gustavo Idalsoaga, Francisco Arnold, Jorge Valverde, María Ayala Perez, Diego Gómez, Jaime Escarate, Rodrigo Villalón, Alejandro Ramírez, Carolina A. Hernandez-Tejero, Maria Zhang, Wei Qian, Steve Simonetto, Douglas A. Ahn, Joseph C. Buryska, Seth Dunn, Winston Mehta, Heer Agrawal, Rohit Cabezas, Joaquín García-Carrera, Inés Cuyàs, Berta Poca, Maria Soriano, German Sarin, Shiv K. Maiwall, Rakhi Jalal, Prasun K. Abdulsada, Saba Higuera-de-la-Tijera, Fátima Kulkarni, Anand V. Rao, P. Nagaraja Salazar, Patricia Guerra Skladaný, Lubomir Bystrianska, Natália Clemente-Sanchez, Ana Villaseca-Gómez, Clara Haider, Tehseen Chacko, Kristina R. Romero, Gustavo A. Pollarsky, Florencia D. Restrepo, Juan Carlos Castro-Sanchez, Susana Toro, Luis G. Yaquich, Pamela Mendizabal, Manuel Garrido, Maria Laura Marciano, Sebastián Dirchwolf, Melisa Vargas, Victor Jiménez, César Louvet, Alexandre García-Tsao, Guadalupe Roblero, Juan Pablo Abraldes, Juan G. Shah, Vijay H. Kamath, Patrick S. Arrese, Marco Singal, Ashwani K. Bataller, Ramon Arab, Juan Pablo